2176–2185 (2006).
81. Treanor, J. J. et al. Protective efﬁcacy of a trivalent recombinant hemagglutinin
protein vaccine (FluBlok(R)) against inﬂuenza in healthy adults: a randomized
placebo-controlled trial. Vaccine 29, 7733–7739 (2011).
82. Belongia, E. A. et al. Clinical trial to assess immunogenicity of high-dose, adju
vanted, and recombinant inﬂuenza vaccines against cell-grown A(H3N2) viruse
in adults 65 to 74 years, 2017-2018. Vaccine 38, 3121–3128 (2020).
83. Shinde, V. et al. Induction of cross-reactive hemagglutination inhibiting antibod
and polyfunctional CD4+ T-cell responses by a recombinant matrix-M
adjuvanted hemagglutinin nanoparticle inﬂuenza vaccine. Clin. Infect. Dis
https://doi.org/10.1093/cid/ciaa1673 (2020).
84. Centers for Disease Control Prevention. Estimates of deaths associated with
seasonal inﬂuenza — United States, 1976-2007. MMWR Morb. Mortal. Wkly Rep
59, 1057–1062 (2010).
85. Goldstein, M. A. & Tauraso, N. M. Effect of formalin, beta-propiolactone, mer
thiolate, and ultraviolet light upon inﬂuenza virus infectivity chicken cell agglu
tination, hemagglutination, and antigenicity. Appl. Microbiol. 19, 290–294 (1970)
86. Uittenbogaard, J. P., Zomer, B., Hoogerhout, P. & Metz, B. Reactions of beta
propiolactone with nucleobase analogues, nucleosides, and peptides: implica
tions for the inactivation of viruses. J. Biol. Chem. 286, 36198–36214 (2011).
87. She, Y. M. et al. Surface modiﬁcations of inﬂuenza proteins upon virus inactiva
tion by β-propiolactone. Proteomics 13, 3537–3547 (2013).
88. Herrera-Rodriguez, J. et al. Inactivated or damaged? Comparing the effect o
inactivation methods on inﬂuenza virions to optimize. Vaccin. Prod. Vaccin. 37
1630–1637 (2019).
89. Li, J. T., Rank, M. A., Squillace, D. L. & Kita, H. Ovalbumin content of inﬂuenza
vaccines. J. Allergy Clin. Immunol. 125, 1412–1413 (2010). author reply 1413-1414
90. Garcia-Canas, V. et al. Selective and quantitative detection of inﬂuenza viru
proteins in commercial vaccines using two-dimensional high-performance liquid
chromatography and ﬂuorescence detection. Anal. Chem. 79, 3164–3172 (2007)
91. Garcia-Canas, V., Lorbetskie, B. & Girard, M. Rapid and selective characterization o
inﬂuenza virus constituents in monovalent and multivalent preparations using
non-porous reversed-phase high performance liquid chromatography columns. J
Chromatogr. A 1123, 225–232 (2006).